Boai NKY Pharmaceuticals Ltd (300109) — Strategic Asset Allocation Index
Boai NKY Pharmaceuticals Ltd (300109) has a Strategic Asset Allocation Index of 28.6% as of June 2023. Strategic assets (PP&E of CN¥926.45 Million plus long-term investments of CN¥-) total CN¥926.45 Million, measured against net assets of CN¥3.24 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Boai NKY Pharmaceuticals Ltd Strategic Asset Allocation Index (2007–2022)
This chart shows how Boai NKY Pharmaceuticals Ltd's Strategic Asset Allocation Index has evolved across 16 annual periods from 2007 to 2022. As of June 2023, the index stands at 28.6%, representing strategic assets of CN¥926.45 Million against net assets of CN¥3.24 Billion CNY. Explore Boai NKY Pharmaceuticals Ltd cash flow conversion to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Boai NKY Pharmaceuticals Ltd (2007–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Boai NKY Pharmaceuticals Ltd from 2007 to 2022, covering 16 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Boai NKY Pharmaceuticals Ltd (300109) total market value.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 27.1% | CN¥844.80 Million | CN¥844.80 Million | CN¥- | CN¥3.12 Billion | ▲ +5.6 pp |
| 2021 | 21.5% | CN¥731.25 Million | CN¥731.25 Million | CN¥- | CN¥3.40 Billion | ▲ +1.6 pp |
| 2020 | 19.9% | CN¥610.95 Million | CN¥610.95 Million | CN¥- | CN¥3.08 Billion | ▲ +1.2 pp |
| 2019 | 18.7% | CN¥569.55 Million | CN¥569.55 Million | CN¥- | CN¥3.05 Billion | ▼ -20.8 pp |
| 2018 | 39.5% | CN¥503.91 Million | CN¥503.91 Million | CN¥- | CN¥1.28 Billion | ▲ +5.3 pp |
| 2017 | 34.2% | CN¥445.61 Million | CN¥445.61 Million | CN¥- | CN¥1.30 Billion | ▲ +4.8 pp |
| 2016 | 29.4% | CN¥360.22 Million | CN¥360.22 Million | CN¥- | CN¥1.23 Billion | ▲ +0.2 pp |
| 2015 | 29.1% | CN¥338.64 Million | CN¥338.64 Million | CN¥- | CN¥1.16 Billion | ▼ -44.1 pp |
| 2014 | 73.2% | CN¥292.89 Million | CN¥292.89 Million | CN¥- | CN¥400.25 Million | ▼ -3.4 pp |
| 2013 | 76.6% | CN¥288.77 Million | CN¥288.77 Million | CN¥- | CN¥377.06 Million | ▲ +5.7 pp |
| 2012 | 70.8% | CN¥257.74 Million | CN¥257.74 Million | CN¥- | CN¥363.81 Million | ▲ +21.8 pp |
| 2011 | 49.0% | CN¥171.97 Million | CN¥171.97 Million | CN¥- | CN¥350.93 Million | ▲ +29.7 pp |
| 2010 | 19.3% | CN¥64.29 Million | CN¥64.29 Million | CN¥- | CN¥333.21 Million | ▼ -32.0 pp |
| 2009 | 51.2% | CN¥31.84 Million | CN¥31.84 Million | CN¥- | CN¥62.14 Million | ▲ +1.8 pp |
| 2008 | 49.4% | CN¥21.71 Million | CN¥21.71 Million | CN¥- | CN¥43.93 Million | ▼ -38.3 pp |
| 2007 | 87.7% | CN¥15.63 Million | CN¥15.63 Million | CN¥- | CN¥17.82 Million | — |